Effects of Parathyroid Hormone on Immune Function

被引:46
作者
Geara, Abdallah Sassine [1 ]
Castellanos, Mario R. [1 ]
Bassil, Claude [1 ]
Schuller-Levis, Georgia [2 ]
Park, Eunkue [2 ]
Smith, Marianne [1 ]
Goldman, Michael [3 ]
Elsayegh, Suzanne
机构
[1] Staten Isl Univ Hosp, Dept Med, Staten Isl, NY 10305 USA
[2] NYS Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
[3] Staten Isl Univ Hosp, Div Nephrol, Staten Isl, NY 10305 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2010年
关键词
CHRONIC-RENAL-FAILURE; OSTEOCLAST-ACTIVATING FACTOR; HEPATITIS-B VACCINATION; T-CELL PROLIFERATION; IMPAIRED PHAGOCYTOSIS; DIALYSIS PATIENTS; IMMUNOGLOBULIN PRODUCTION; RANDOM MIGRATION; UREMIC PATIENTS; HEMODIALYSIS;
D O I
10.1155/2010/418695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parathyroid hormone (PTH) function as immunologic mediator has become interesting with the recent usage of PTH analogue (teriparatide) in the management of osteoporosis. Since the early 1980s, PTH receptors were found on most immunologic cells (neutrophils, B and T cells). The in vitro evaluations for a possible role of PTH as immunomodulator have shown inconsistent results mainly due to methodological heterogeneity of these studies: it used different PTH formulations (rat, bovine, and human), at different dosages and different incubating periods. In some of these studies, the lymphocytes were collected from uremic patients or animals, which renders the interpretation of the results problematic due to the effect of uremic toxins. Parathyroidectomy has been found to reverse the immunologic defect in patients with high PTH levels. Nonetheless, the clinical significance of these findings is unclear. Further studies are needed to define if PTH does have immunomodulatory effects.
引用
收藏
页数:10
相关论文
共 74 条
  • [1] ALEXIEWICZ JM, 1990, J AM SOC NEPHROL, V1, P236
  • [2] IMPAIRED PHAGOCYTOSIS IN DIALYSIS PATIENTS - STUDIES ON MECHANISMS
    ALEXIEWICZ, JM
    SMOGORZEWSKI, M
    FADDA, GZ
    MASSRY, SG
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (02) : 102 - 111
  • [3] Time course of the effect of nifedipine therapy and its discontinuation on [Ca2+](i) and phagocytosis of polymorphonuclear leukocytes from hemodialysis patients
    Alexiewicz, JM
    Smogorzewski, M
    Gill, SK
    Akmal, M
    Massry, SG
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (01) : 12 - 16
  • [4] EFFECT OF TREATMENT OF HEMODIALYSIS-PATIENTS WITH NIFEDIPINE ON METABOLISM AND FUNCTION OF POLYMORPHONUCLEAR
    ALEXIEWICZ, JM
    SMOGORZEWSKI, M
    KLIN, M
    AKMAL, M
    MASSRY, SG
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 440 - 444
  • [5] ANGELINI D, 1993, ARTIF ORGANS, V17, P73
  • [6] ANGELINI D, 1994, CLIN NEPHROL, V42, P246
  • [7] Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism
    Ayturk, Semra
    Gursoy, Alptekin
    Tutuncu, Neslihan Bascil
    Ertugrul, Derun Taner
    Demirag, Nilgun Guvener
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4260 - 4263
  • [8] BINDING OF BOVINE PARATHYROID-HORMONE TO SURFACE-RECEPTORS OF CULTURED LYMPHOCYTES-B
    BIALASIEWICZ, AA
    JUPPNER, H
    DIEHL, V
    HESCH, RD
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 584 (03) : 467 - 478
  • [9] BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137
  • [10] EFFECT OF PARATHYROID-HORMONE ON OSMOTIC FRAGILITY OF HUMAN-ERYTHROCYTES
    BOGIN, E
    MASSRY, SG
    LEVI, J
    DJALDETI, M
    BRISTOL, G
    SMITH, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) : 1017 - 1025